Document Detail


Molecular attributes of dopamine receptors: new potential for antipsychotic drug development.
MedLine Citation:
PMID:  8811164     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The neurotransmitter dopamine (DA) plays a central role in the control of motor function, emotional states, and endocrine physiology. The discovery that schizophrenic symptoms can be alleviated by neuroleptic drugs and the finding that these drugs interact at dopamine receptors has indicated involvement of the dopamine system in schizophrenia. The dopamine system has recently been shown to rely on the activation of five distinct subtypes of DA receptors (D1-D5) identified by molecular cloning, and pharmacological studies have specifically implicated the D2-like receptors (D2R, D3R and D4R) in antipsychotic action. In addition, the localization of D3R and D4R expression in the mesolimbic/mesocortical DA pathways is consistent with their proposed involvement in affective behaviour, and suggests that drugs developed specifically for these receptor subtypes might have potent antipsychotic activity with a lower propensity for extrapyramidal, endocrine, and cognitive side-effects.
Authors:
D S Hartman; O Civelli
Related Documents :
9711974 - Do dopamine agonists provide neuroprotection?
9075264 - Cloning, expression and characterization of a human dopamine d4.2 receptor (cho k1 cell...
18831004 - Altered nicotinamide adenine dinucleotide (nadh) fluorescence in dt sz mutant hamsters ...
23266674 - Inhibition of constitutive aryl hydrocarbon receptor (ahr) signaling attenuates androge...
9143704 - Human chemokines: an update.
16828734 - The role of megalin (lrp-2/gp330) during development.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of medicine     Volume:  28     ISSN:  0785-3890     ISO Abbreviation:  Ann. Med.     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-12-04     Completed Date:  1996-12-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8906388     Medline TA:  Ann Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  211-9     Citation Subset:  IM    
Affiliation:
Pharma Research, Preclinical Neurosciences, F. Hoffmann-La Roche AG, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antipsychotic Agents / pharmacology*,  therapeutic use
Humans
Receptors, Dopamine* / drug effects,  metabolism
Schizophrenia* / drug therapy,  physiopathology
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Receptors, Dopamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Leucocyte adhesion molecules in host defence against infection.
Next Document:  Early intervention for low-birth-weight premature infants: what can we achieve?